The widely projecting catecholaminergic (norepinephrine and dopamine) neurotransmitter systems 2 profoundly shape the state of neuronal networks in the forebrain. Current models posit that the effects 3 of catecholaminergic modulation on network dynamics are homogenous across the brain. However, 4 the brain is equipped with a variety of catecholamine receptors with distinct functional effects and 5 heterogeneous density across brain regions. Consequently, catecholaminergic effects on brain-wide 6 network dynamics might be more spatially specific than assumed. We tested this idea through the 7 analysis of functional magnetic resonance imaging (fMRI) measurements performed in humans (19 8 females, 5 males) at 'rest' under pharmacological (atomoxetine-induced) elevation of catecholamine 9 levels. We used a linear decomposition technique to identify spatial patterns of correlated fMRI signal 10 fluctuations that were either increased or decreased by atomoxetine. This yielded two distinct spatial 11 patterns, each expressing reliable and specific drug effects. The spatial structure of both fluctuation 12 patterns resembled the spatial distribution of the expression of catecholamine receptor genes: α1 13 norepinephrine receptors (for the fluctuation pattern: placebo > atomoxetine), 'D2-like' dopamine 14 receptors (pattern: atomoxetine > placebo), and β norepinephrine receptors (for both patterns, with 15 correlations of opposite sign). We conclude that catecholaminergic effects on the forebrain are 16 spatially more structured than traditionally assumed and at least in part explained by the 17 heterogeneous distribution of various catecholamine receptors. Our findings link catecholaminergic 18 effects on large-scale brain networks to low-level characteristics of the underlying neurotransmitter 19 systems. They also provide key constraints for the development of realistic models of 20 neuromodulatory effects on large-scale brain network dynamics. 21 state of neuronal networks in the cerebral cortex. Catecholamines, an important class of 35 neuromodulators including norepinephrine (NE) and dopamine (DA), amplify the gain of neuronal 36 responses to sensory input (Berridge and Waterhouse, 2003; Winterer and Weinberger, 2004; Jacob et 37 al., 2013; Polack et al., 2013) . Current models of catecholaminergic modulation posit that this 38 increase in response gain amplifies the signal-to-noise ratio of sensory responses at the network level 39 (Servan-Schreiber et al., 1990; Aston-Jones and Cohen, 2005; Eckhoff et al., 2009; Shine et al., 40 2018). An assumption common to these models is that catecholamines boost neural gain 41 homogenously across the entire brain. This assumption is grounded in the widespread projections of 42 the brainstem structures releasing these neuromodulators, in particular the locus coeruleus (LC), the 43 main source of NE in the forebrain (Aston-Jones and Cohen, 2005) . 44
The catecholamines norepinephrine and dopamine are an important class of modulatory 23 neurotransmitters. Because of the widespread and diffuse release of these neuromodulators, it has 24 commonly been assumed that their effects on neural interactions are homogenous across the brain. 25
Here, we present results from the human brain that challenge this view. We pharmacologically 26 increased catecholamine levels and imaged the effects on the spontaneous covariations between brain-27 wide fMRI signals at 'rest'. We identified two distinct spatial patterns of covariations: one that was 28 amplified and another that was suppressed by catecholamines. Each pattern was associated with the 29 heterogeneous spatial distribution of the expression of distinct catecholamine receptor genes. Our 30 results provide novel insights into the catecholaminergic modulation of large-scale human brain 31 dynamics. 32
INTRODUCTION
types exhibit distinct functional effects on cortical state (McCormick et al., 1991; Ramos and Arnsten, 48 2007; Robbins and Arnsten, 2009; Noudoost and Moore, 2011; Salgado et al., 2016) . As a 49 consequence, the effects of catecholamines on neural dynamics might be more spatially specific than 50 traditionally assumed, perhaps even with opposing signs between different sets of brain regions. Here, 51 we tested this idea by imaging the spatial distribution of catecholamine-induced changes in large-52 scale human brain dynamics, and relating the resulting patterns of brain dynamics to the spatial 53 distribution of several catecholamine receptor types. 54 fMRI signals fluctuate strongly in the absence of changes in sensory input and motor output 55 (often called 'resting-state'), and these fluctuations correlate between distributed brain regions 56 (Biswal et al., 1995; Fox and Raichle, 2007; Schölvinck et al., 2010) . In the following, we refer to this 57 phenomenon as intrinsic fMRI signal correlations, or simply, correlations. We have previously 58 examined the effect of increasing central catecholamine levels on intrinsic fMRI signal correlations in Inter-regional covariance of fMRI signal fluctuations 116 After averaging across voxels within each atlas-level brain region, we Z-scored the 117 multivariate time series (M, with dimensionality imaging volumes by brain regions) for each run i and 118 then computed the group-averaged covariance matrices (C) for the placebo and atomoxetine 119 conditions (subscript P and A, respectively) via the following: 120
(1)
where nTR was the number of volumes (211) , N was the number of participants (24), and T denoted a 122 matrix transposition. The matrices CP and CA represented the covariance between the BOLD time 123 series of all brain regions, averaged across participants. Note that by Z-scoring the time series, the 124 The so-computed t described the time-varying strength of the expression of the spatial mode 149 (functional network) in each individual participant's data, in one condition. We used t to produce 150 voxel-level spatial maps of the corresponding modes in order to examine their correspondence with 151 ICA-derived cofluctuating networks (see below). Next, we describe the generalization of eigenvalue 152 decomposition to extract modes that are more strongly expressed in one condition relative to the 153 other. 154 155 Generalized eigenvalue decomposition of covariance matrices 156 We used generalized eigenvalue decomposition to decompose the covariance matrices from decomposed the participant-averaged atomoxetine covariance matrix CA and placebo covariance 162 matrix CP by solving the equation: 163
where λ was an n-by-n matrix with generalized eigenvalues on its diagonal, and V was an n-by-n 165 matrix of corresponding eigenvectors in which rows were brain regions (n = 90 for the AAL atlas, 166 and n = 140 for the Craddock atlas) and columns defined individual modes (p). As above, p was a 167 
172
The covariance matrices CA and CP are submitted to generalized eigenvalue decomposition to produce a matrix 173 of eigenvalues (λ) and eigenvectors (V). The decomposition equation as given here delineated modes that were 174 more strongly expressed in the atomoxetine condition than in the placebo condition. To identify modes that 10 that fluctuated more strongly in the atomoxetine condition than in the placebo condition. To identify 183 spatial modes that fluctuated more strongly in the placebo condition, the covariance matrices CA and 184 CP were swapped. We arranged V and λ such that their first entries corresponded to the modes that 185 explained most variance. In other words, we sorted λ in descending order and then sorted V by λ. 186
For each run i, we calculated participant-level time series ti corresponding to each spatial 187 mode p for each individual run i as follows: 188
Here, ti was a vector with length 211 (the number of volumes), and Mi was a matrix of Z-scored fMRI 190 time series from the run, with size 211 by n (volumes by brain regions). 191
192
Quantifying the across-subject consistency and reliability of spatial modes 193 The spatial modes were computed such that they explained more variance in the group-194 average data in the atomoxetine condition than in the placebo condition (or the converse). We aimed 195 to quantify, in a cross-validated fashion, how consistently the fluctuation strength of these group-196 average spatial modes distinguished between conditions within individual subjects. The fluctuation 197
amplitude si corresponding to each mode's time series in each individual run from each participant 198 quantified the amount of variance that the mode explained in the data, and was calculated via: 199
where T denoted transposition. Note that this was equivalent to: 201
We divided si by the sum of eigenvalues (λ) to convert it to units of percentage variance explained. In 203 contrast to the eigenvalues, which captured the group-level mode's ratio of explained variance 204 between conditions, si captured the amount of variance that the mode captured in the condition-205 specific runs at the individual participant-level. For cross-validation, we defined modes (using eq. 4) 206 based on the group-average covariance matrices CA and CP that were generated from the first half of 207 volumes in Mi (using eq. 1). Each mode was projected onto independent data: the remaining half of 208 volumes in Mi as described above (eq. 5). Their corresponding fluctuation amplitudes were calculated 209 (via eq. 6). We then used the second half of volumes to define the modes and projected them onto the 210 first half, and averaged the two values of si. The percentage variance explained by each mode could 211 then be compared between conditions with non-parametric permutation testing (10,000 iterations). 212
We used receiver operating characteristic (ROC) analysis (Green and Swets, 1966) to 213 quantify the reliability of the spatial modes in discriminating between experimental conditions, at the 214 level of short segments (25% of volumes, ~114 s) of the fMRI runs. ROC analysis performs more 215 accurately with densely populated distributions of measurements. Thus, we defined spatial modes 216 based on the group average covariance matrices calculated from a smaller subset of volumes (25%), 217 as described above (using eq. 1 and eq. 4). We subdivided the remainder of volumes into 20 equal-218 sized bins, and computed (participant-level) si for each of them. We cross-validated the fluctuation 219 amplitude calculation by computing modes and projecting them onto the remaining data four times, 220 such that eventually all data were used to define the modes. This yielded four distributions of si per 221 condition and participant that were submitted to ROC analysis, resulting in four ROC curves per 222 participant. We calculated the area under the ROC curve, referred to as 'ROC index' in the following, 223 and averaged the resulting ROC indices across the four ROC curves of each participant. The resulting 224 ROC indices could range between 0 and 1 and could be interpreted as the probability with which we 225 could predict the condition from the mode's fluctuation strength in a given data segment. The ROC 226 indices were tested for significance by comparing them to chance level (0.5) using non-parametric 227 permutation testing (10,000 iterations). In order to exclude the possibility that the significance of the 228 ROC results depended on the number (25%) of volumes on which the mode was defined, we repeated 229 the ROC analyses for modes defined on ~14%, 20%, and ~33% of the data, and found identical 230 results in terms of direction and significance. 231
232
Imaging the spatial modes 233 The spatial modes were computed using atlas-level covariance matrices because the whole-234 brain covariance matrices could not be robustly estimated at the single-voxel level (substantially more 235 voxels in the brain than samples in the time dimension). A central aim of our study was to image the 236 neuroanatomical distribution of the spatial modes at the single-voxel level. To this end, we used the 237 following approach. For each participant and condition separately, we regressed the spatial mode time 238 series ti (see eq. 5) onto the multivariate (voxel-level) time series from the corresponding run i. This 239 yielded a map of regression coefficients per participant, condition, mode, and run. For each mode and 240 for each condition, we could then compare the regression coefficients to zero using non-parametric 241 permutation testing (10,000 iterations). The α level was set at 0.05, FWE corrected for multiple 242 comparisons using threshold-free cluster enhancement (Smith and Nichols, 2009 
Validation of spatial modes via independent component analysis
247 Independent component analysis (ICA) is an often-used approach to delineate so-called 248 'resting-state networks' of intrinsic fMRI signal covariations (Beckmann et al., 2005) . We applied 249 ICA in order to validate the use of eigenvalue decomposition and to examine the correspondence 250 between spatial modes and well-characterized 'resting-state networks'. We first estimated a set of 251 independent components (ICs) that were representative of the combined set of resting-state runs (i.e., 252 runs from all participants and both the atomoxetine and placebo conditions) by applying a spatial ICA 253 to all temporally concatenated data using FSL's MELODIC. The model order (51) was automatically 254 estimated from the data following the methods described by Beckmann et al. (2005) . Each IC 255 represented a statistical parametric map and corresponding time series of consistent spatio-temporal 256 dynamics. Next, we spatially correlated each IC spatial map with the 10 'resting-state networks' 257 reported by and selected the ICs that showed the highest correlation coefficient. 258
The selected components showed an average correlation coefficient of 0.48 (range: 0.28 -0.70), 259
which indicated that the ICs as expressed in our data corresponded relatively well to previously 260 reported 'resting-state networks' . 261
The 10 selected ICs were reliably expressed across the combined set of resting-state runs, and 262
were thus representative of group-level spatiotemporal dynamics. However, the ICs did not 13 necessarily represent spatiotemporal dynamics within individual runs. To produce a time series and a 264 spatial map for the individual resting-state runs, we used the group-level IC spatial maps in multiple 265 spatial regression onto the individual runs. This produced a time series for each IC as expressed 266 within the individual runs. Then, in a second step, we used the participant-level time series as 267 temporal regressors to produce spatial maps of regression coefficients for each component and each 268 run. Thus, this two-stage regression approach resulted in a spatial map for each participant, condition, 269 and IC, that indicated the degree of covariation between individual voxels and the IC time series. 270
To quantify the correspondence between the spatial modes and ICA-based 'resting-state 271 networks', we first repeated the procedure described in the section Imaging the Spatial Modes above, 272 but now on the data concatenated across the two runs runs per participant. The purpose of this 273 concatenation procedure was to create spatial maps that were independent of the drug condition, 274 similar to the ICs. We then correlated, across voxels, the spatial modes with the selected ICs, 275 separately for each participant. We finally compared the distribution of Fisher r-to-Z transformed 276 correlation coefficients to zero using a two-tailed t-test. 277
We also determined if standard eigenvalue decomposition identified similar spatial patterns to 278 the more commonly used ICA. We first produced voxel-level spatial maps of the modes that were 279 derived from eigenvalue decomposition of AAL atlas-level covariance in the individual conditions, 280 using multiple temporal regression. We then selected modes based on maximal spatial correlation 281 with the 10 intrinsic connectivity networks reported by , similar to the selection of 282 ICA components described above. Finally, we examined the strength of correlation between the 283 selected voxel-level spatial mode maps and the intrinsic connectivity networks reported by Smith et 284 al. (2009) . 285 286 Similarity between spatial modes from different parcellation schemes 287 We used spatial correlation to determine if the generalized eigenvalue decomposition-derived 288 mode spatial maps depended on the parcellation scheme. For each individual participant and 289 condition, we correlated the (unthresholded) spatial maps of regression coefficients of the modes that 290 were generated with the AAL atlas, and those that were generated with the Craddock atlas. We then 291 compared the distribution of Fisher-transformed correlation coefficients to zero using a two-tailed t-292 test. Similarly, we characterized the correspondence in mode spatial maps between the individual 293 conditions by correlating the unthresholded spatial maps at the individual participant level, and 294 comparing the resulting distribution of Fisher-transformed correlation coefficients to zero using a 295 two-tailed t-test. 296 297
Similarity between spatial modes and catecholamine receptor expression maps 298
We used a dataset provided by the Allen Brain Institute (Hawrylycz et al., 2012; Hawrylycz 299 et al., 2015) (http://www.brain-map.org/) to quantify the similarity between the spatial modes 300
(computed based on signal fluctuations as described above) and the spatial maps of the expression of 301 specific catecholamine receptors. The Hawrylycz et al. (2015) dataset comprised post-mortem 302 samples of 6 individuals that underwent microarray transcriptional profiling. Spatial maps of each 303 sample's gene transcription profile were available in MNI space, following improved non-linear 304 registration as implemented by Gorgolewski et al. (2014) . Receptors mediate the effect of 305 neuromodulators on post-synaptic neurons and, consequently, neural network dynamics. In the current 306 article we thus focused on the expression of clusters of genes that encode receptors with varying 307 subunit compositions but functionally analogous post-synaptic effects (e.g. due to being coupled to 308 inhibitory or excitatory G-proteins). Specifically, we grouped the 14 available catecholamine 309 receptor-related genes into 5 classes according to functional receptor type: norepinephrine receptor α1 310 (ADRA1A, ADRA1B, ADRA1D); norepinephrine receptor α2 (ADRA2A, ADRA2B, ADRA2C); 311 norepinephrine receptor β (ADRB1, ADRB2, ADRB3); and dopamine 'D1-like' (DRD1, DRD5) and 312 'D2-like' (DRD2, DRD3, DRD4) receptors (Cools and van Rossum, 1976; Surmeier et al., 2007; 313 Arnsten, 2011) . 314
We used two groups of "reference" receptors in order to examine the specificity of the spatial 315 similarity measures for catecholamine receptors. First, because the cholinergic system has a gross projections), we used an additional 16 genes related to acetylcholine receptors as a reference. Those 318 were grouped into two classes, again according to functional receptor type: nicotinic acetylcholine 319 receptor (AChN) (CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, 320 CHRNA10, CHRNB2, CHRNB3, CHRNB4) and muscarinic acetylcholine receptor (AChM) 321 (CHRM1, CHRM2, CHRM3, CHRM4, CHRM5). Second, because atomoxetine also blocks NMDA 322 receptors (Ludolph et al., 2010) , we selected 7 genes related to the expression of NMDA receptors 323 (GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B). These genes were grouped 324 into one class because NMDA receptor blockade by atomoxetine is similar across receptors with 325 varying subunit compositions (Ludolph et al., 2010) . 326
Spatial similarity (i.e., correlation) between gene expression and spatial modes (imaged at the 327 single-voxel level, see above) was computed on an individual participant basis by linear regression 328 across sequenced parcels. Because the post-mortem samples differed in the coverage of sequenced 329 parcels, we repeated this procedure for each individual post-mortem sample. A t-test was then 330 conducted across samples to obtain a test statistic that quantified the robustness of the spatial 331 correlation across the 6 post-mortem samples (Gorgolewski et al., 2014) . For each of our participants, 332
we then collapsed across genes within each receptor class (α1, α2, β, D1-like, D2-like, AChN, AChM, 333 and NMDA). To assess the robustness of correlations across our participants (in addition to within 334 participants across samples), we compared the distribution of t-statistics of the catecholamine 335 receptors to zero, and to the t-statistics of the acetylcholine receptors and NMDA receptors, by means 336 of non-parametric permutation testing (10,000 iterations). Significant differences of t-values were 337 indicative of a relationship between the expression of specific catecholamine receptors and the spatial 338 distribution of the modes that was reliable across both post-mortem samples and across our 339
participants. 340
Acetylcholine receptors were unrelated to the spatial mode maps, and Bayes factors indicated 341 "substantial" evidence (Wetzels and Wagenmakers, 2012) for the null hypothesis of no correlation 342 (AChN and spatial mode atomoxetine > placebo: p = 0.28, BF = 0.157; for AChN and spatial mode 343 placebo > atomoxetine: p = 0.15, BF = 0.156; for AChM and spatial mode atomoxetine > placebo: p receptors (spatial mode atomoxetine > placebo versus spatial mode placebo > atomoxetine, AChN,: p 347 = 0.07; AChM, p = 0.31). We thus collapsed across acetylcholine receptors and used this summary 348 statistic as reference for testing the mode versus receptor map associations for the catecholamine 349 receptors. Similarly, we found no significant associations between NMDA receptors and spatial 350 modes, and Bayes factors indicated "substantial" evidence for the absence of a correlation 351 (atomoxetine > placebo: p = 0.81, BF = 0.157; placebo > atomoxetine: p = 0.11, BF = 0.156), and 352 thus used NMDA receptors as an additional reference. 353 354 Separating spatial modes from noise 355 We calculated the theoretical distribution ρ of eigenvalues λ under the null hypothesis of no 356 difference between conditions, and was given by the following: 357
and σ was the standard deviation of λ, and p and q were the dimensions of the covariance matrix. We 361 then fitted ρ to λ by minimizing the sum of squared residuals of ρ multiplied by a scalar value (Mitra 362 and Pesaran, 1999) . 363
If between-condition differences in signal correlation strength were "noise" (i.e., 364 independently normally distributed with zero mean), the eigenvalues should not have differed from 365 the theoretical distribution (Mitra and Pesaran, 1999) . If, by contrast, the between-condition 366 differences in correlation strength were "signal", the eigenvalues of modes with a low rank number 367 should have exceeded the theoretical distribution more so than modes with a high rank number, 368 reflecting a skewed eigenvalue distribution. We thus calculated the difference between the 369 eigenvalues and the theoretical distribution and categorized modes into "signal" and "noise". Modes 370 for which λ > ρ were categorized as signal; the remaining modes were categorized as noise. This 371 procedure provided an upper bound for the number of modes that we could consider as possibly 372 reflecting atomoxetine-related changes in intrinsic signal correlation strength. 373 above the subsequent spatial modes classified as signal (see previous section). First, we determined if 378 all signal modes with a lower rank number tended to explain more variance in independent data than 379 modes with a high rank number, using the cross-validated ROC analysis described above. If so, the 380 ROC index should decline with mode rank. Note that this prediction was not trivial given that in the 381 cross-validation procedure the modes were projected onto independent data. We tested this prediction 382 by correlating ROC index with mode rank within participants and comparing the distribution of 383 correlation coefficients to zero across participants using permutation testing (10,000 iterations, one-384 tailed test). 385
Second, we determined if the spatial correspondence between modes and catecholamine 386 receptors was stronger for the first mode than for the subsequent signal modes (i.e., rank numbers > 387 1). We used permutation tests to compare the corresponding spatial correlations between mode one 388 and the remaining modes: once by collapsing correlations across signal modes and once for all 389 subsequent modes individually. 390 391 Control analysis for mode specificity 392 Spatial mode decomposition (eqn. 4) can only be used to compare two individual conditions 393 (or groups): here, the placebo and atomoxetine conditions. However, the fMRI measurements of the 394 atomoxetine and placebo conditions were conducted on separate days. Thus, it is possible that spatial 395 modes reflected session-related effects rather than drug treatment-related effects. To control for this 396 possibility, we projected the spatial modes onto the multivariate fMRI data (using eqn. 5) of the pre-397 pill measurements that were conducted on the same days as the post-pill ingestion measurements, and 398 calculated the strength of the fluctuation of the resulting time series (using eqn 6.). We then used the 399 percentage of variance explained in the pre-pill measurements as a baseline in the interaction contrast 400 (atomoxetine -pre atomoxetine) -(placebo -pre placebo). 401
Second, we computed spatial modes based on covariance in the pre-pill ingestion conditions, 402
and compared (using spatial correlation) the resulting spatial maps to those that were computed using 403 the post-pill measurements. We then compared the distribution of correlation coefficients across 404 participants to zero using permutation testing. modulation of large-scale brain dynamics and relate it to the spatial distribution of catecholamine 412 receptors. To this end, we imaged atomoxetine-induced alterations (increases and decreases) in the 413 strength of correlated fMRI signal fluctuations across the whole human brain, and related the resulting 414 spatial maps (referred to as 'spatial modes', see Materials and Methods) to maps of catechacholamine 415 receptor gene expression derived from post-mortem brains (Hawrylycz et al., 2012; Hawrylycz et al., 416 2015) . We used a linear decomposition approach, which we previously validated by means of fMRI 417 retinotopic mapping protocols (Donner et al., 2013) , and which was tailored to finding the two spatial 418 modes that fluctuated more strongly (referred to as 'atomoxetine > placebo') or less strongly 419 ('placebo > atomoxetine') during the atomoxetine condition than during the placebo condition ( Figure  420 1 and Materials and Methods). This analysis enabled imaging the brain-wide distribution of the 421 strongest catecholamine-induced increases and decreases in correlated signal fluctuations, thus 422 assessing their fine-grained neuroanatomical distribution. Furthermore, the analysis enabled us to 423 quantify the similarity between the spatial modes that captured catecholaminergic modulation of brain 424 dynamics on the one hand, and the spatial distribution of the expression of specific catecholamine 425 receptor genes on the other hand. The latter was taken from a dataset provided by the Allen Brain 426
Institute (Hawrylycz et al., 2012; Hawrylycz et al., 2015) . 427
The Results section is organized as follows. We first describe the spatial modes that show the 428 strongest drug-induced changes (increases and decreases) in correlated signal fluctuations. We then 429 evaluate the relationship between both of these spatial modes and catecholamine receptor gene 430 expression maps. Finally, we present a number of control analyses that support the specificity and 431 validity of the spatial modes of drug-related changes in brain dynamics. 432 433 Spatial modes fluctuating more strongly during atomoxetine than placebo 434 Our previously published analyses of the same data (van den Brink et al., 2016) identified exhibiting the strongest increase in fluctuation amplitude during the atomoxetine condition, and 441 because mode orthogonality can obscure the interpretation of modes with higher ranks (c.f. Donner et 442 al., 2013) . 443
The spatial mode was comprised of a set of weights (one value per brain region in the 444 parcellation scheme) that indicated relative cofluctuation between brain areas (Figure 2b) . Please note 445 that the overall sign of mode weights was arbitrary, but the sign of one element with respect to gyrus, left calcarine fissure and surrounding cortex, and in the left supplementary motor area. Across 450 the brain, the weights were anti-correlated between hemispheres (r = -0.56, p < 0.001) such that if the 451 mode weight of one brain region was positive then the weight of the homotopic region in the other 452 hemisphere tended to be negative. This suggests that this spatial mode possibly reflected an increase 453 in the mutual inhibition between hemispheres. 454
The spatial mode shown in Figure 2b was a coarse (atlas-level) representation of the spatial 455 distribution of the corresponding brain dynamics, which was necessary for technical reasons 456 (Materials and Methods). Regressing the time series of the fluctuation of this spatial mode onto each 457 participant's multivariate data enabled us to image this spatial distribution at a finer (voxel-level) 458 granularity, as well as test for the consistency of the expression of the corresponding spatial mode 459 across participants within individual conditions (Figure 2c ). This analysis yielded a single significant 460 cluster (superior frontal gyrus) for the placebo condition, and a number of significant clusters (36% of 461 all brain voxels) for the atomoxetine condition. Cluster maxima were located in bilateral anterior 462 cingulate cortex, right medial frontal gyrus, right lingual gyrus, left precentral gyrus, left lateral 
477
To determine if the spatial mode corresponded to any of the so-called 'resting-state 478 networks', as defined with commonly used ICA approaches (Beckmann, 2009; , we 479 correlated the spatial mode with each of the 10 selected ICA components (see Materials and Methods) for each individual participant. This yielded a weak, albeit statistically significant, correlation of the 481 spatial mode with the right-lateralized frontoparietal ICA component (mean r = -0.05, SD 0.03; t(23) 482 = -7.89, p < 0.001). Taken together, our analysis revealed a pattern of intrinsic fMRI signal 483 correlations that were enhanced under atomoxetine, which exhibited a highly structured spatial 484 organization (Figure 2c ), but only loosely resembled any of the established resting-state networks 485 defined using standard ICA-based analyses of correlated signal fluctuations irrespective of 486 pharmacological intervention. In the section Spatial Modes Reflect Gene Expression of 487
Catecholamine Receptors, we link this spatial organization to the distribution of specific 488 catecholamine receptors across the brain. 489
We finally verified, using cross-validated procedures (Materials and Methods), the robustness 490 and reliability of the fluctuations captured by the spatial mode: The fluctuation strength of the spatial 491 mode was consistently larger in the atomoxetine than placebo condition (p < 0.001; Figure 2d ), and it 492 reliably discriminated between the two pharmacological conditions, even on the basis of short 493 individual data segments (group average ROC index = 0.62, p = 0.002; Figure 2e ). was not suited to image the fine-grained neuroanatomical structure of these decreases. By contrast, 499 our current decomposition approach suited this purpose, and it uncovered a widespread set of brain 500 regions between which correlations were suppressed by atomoxetine ( Figure 3 ). The first spatial mode 501 resulting from this decomposition (again selected based on its largest eigenvalue, Figure 3a ) had local 502 maxima and minima in homotopic regions of both hemispheres (Figure 3b) , with an even stronger 503 overall negative correlation between hemispheres (r = -0.79, p < 0.001) than evident for the spatial 504 mode for atomoxetine-induced increases (compare to Figure 2b ). This effect might indicate an Importantly, this spatial mode for placebo > atomoxetine was uncorrelated (r = -0.013, p = 507 0.88, Bayes Factor = 0.157) with the one for atomoxetine > placebo (Figure 2b) . Thus, the spatial 508 modes resulting from both decompositions reflected distinct sets of brain regions, in which the 509 510 511 Again, we imaged the fine-grained (voxel-level) distribution of this fluctuation pattern within 522 individual conditions. This revealed a large proportion of significant voxels (51% of all brain voxels) 523 in the placebo condition (Figure 3e ). The spatial mode exhibited local maxima or minima in regions 524 of the so-called 'default mode' and 'attention networks' (Fox et al., 2006; bilateral 525 temporal poles, medial frontal, lateral occipital, and posterior cingulate cortices, and in bilateral 526 paracingulate, precentral, superior frontal, supramarginal, and paracingulate gyri. Indeed, the spatial 527 mode weakly, but significantly and most strongly, resembled the left-lateralized 'frontoparietal' ICA 528 component (mean r = -0.15, SD 0.05; t(23) = -16.33, p < 0.001). Given that the first spatial mode in 529 the decomposition atomoxetine > placebo correlated most strongly with the right lateralized 530 frontoparietal network, this suggested that atomoxetine resulted in a shift from left-to right-lateralized 531 frontoparietal dominance. A significant interaction in the strength of correlation between mode 532 polarity (atomoxetine-induced increase versus decrease) and ICA component (frontoparietal left 533 versus right) suggested that this was indeed the case (repeated-measures ANOVA; F(1,23) = 163.14, 534 p < 0.001). Other significant correlations were evident for the 'default mode' (mean r = -0.15, SD 535 0.05; t(23) = -14.19, p < 0001) and 'sensorimotor' (mean r = 0.13, SD 0.04; t(23) = 17.41, p < 0.001) 536
ICA components. 537
The fluctuation of this spatial mode was a consistent and reliable indicator of the drug 538 condition across participants, even for short segments of data (comparison of mode variance between 539 atomoxetine and placebo: p < 0.001; group average ROC index = 0.62, p = 0.002; Figure 3d ,e). 540 541
Spatial modes reflect gene expression of catecholamine receptors 542
Our analyses thus far established that atomoxetine both increased and decreased intrinsic 543 fMRI signal correlations in two distinct sets of widely distributed brain regions. How can the systemic 544 increase in catecholamine levels by atomoxetine lead to regionally specific, and even opposite-545 polarity modulations of brain dynamics? An attractive possibility is that such heterogeneous 546 functional effects are mediated by the heterogeneous distribution of catecholamine receptors across 547 the brain (Ramos and Arnsten, 2007) . To test this idea, we quantified the spatial similarity between 548 spatial modes and maps of the expression of genes encoding a variety of catecholamine receptors. 549
Gene maps were taken from human post-mortem samples from the Allen Brain Institute 550 (Hawrylycz et al., 2012; Hawrylycz et al., 2015) and examples are shown in Figure 4a . We found a 551 specific, and distinct, association pattern for both spatial modes identified here (Figure 4b) . First, the 552 spatial mode that fluctuated more strongly in the atomoxetine than the placebo condition was 553 associated with the genetic expression map of D2-like dopamine receptors. Second, by contrast, the 554 spatial mode that fluctuated more strongly in the placebo than atomoxetine condition was associated 555 with genetic expression of the α1 norepinephrine receptor. Third, both spatial modes were associated 556 with the β norepinephrine receptor gene map, but with opposite sign. 557
To assess the specificity of these spatial correlations (Materials and Methods) we compared 558 them with two "reference" correlations: (i) correlations with maps of genes coding for acetylcholine 559 receptors, and (ii) correlations with maps of genes coding for NMDA receptors. We chose 560 acetylcholine because it is another neuromodulaory system with a functional organization similar to 561 that of the NE system, but had no relation to our drug manipulation. We chose NMDA receptors 562 because atomoxetine binds to, and inhibits, them at clinically relevant doses (Ludolph et al., 2010) . 563
The distributions of acetylcholine receptors and NMDA were uncorrelated with the spatial mode 564 maps (all Bayes Factors: 0 < BF < 0.158; see Materials and Methods), and there were no significant 565 differences between the muscarinic and nicotinic acetylcholine receptors (Figure 4b , rightmost panel 566
and Materials and Methods for details). 567
All the significant associations between spatial modes and catecholamine receptors shown in 568 Figure 4b were also significant when compared to ACh receptor maps combined or to NMDA 569 receptor maps (Comparison with ACh receptors: spatial mode atomoxetine > placebo: ARβ, p = 570 0.011; D2-like receptors, p = 0.009; spatial mode placebo > atomoxetine: ARα1, p = 0.011; ARβ, p = 571 0.010; Comparison with NMDA receptors: spatial mode atomoxetine > placebo: ARβ, p = 0.026; D2-572 like receptors, p = 0.003; spatial mode placebo > atomoxetine: ARα1, p = 0.002; ARβ, p = 0.003). 573
Furthermore, similar results were obtained when the analysis was confined to the cortex rather than 574 the whole brain, except that the association between the β norepinephrine receptor map and the spatial 575
In sum, the spatial association analyses reported here link the brain-wide distribution of 604 catecholaminergic effects on large-scale neural dynamics to the distribution of different 605 catecholamine receptor types, with important implications for understanding the principles of 606 cathecholaminergic modulation (see Discussion). In the remainder of Results section, we present a 607 number of control analyses, which corroborated the specificity and validity of the interpretation of our 608 main findings. It is possible that spatial modes other than the first mode we focused on here, captured 613 meaningful relationships between the spatial distributions of catecholamine receptors and the 614 distribution of atomoxetine-related changes in fMRI signal correlations. To assess the relevance of 615 spatial modes with higher ranks, we computed a theoretical distribution of eigenvalues under the null 616 hypotheses of no between-condition differences in correlations, and compared it to the observed 617 eigenvalue distribution (see Materials and Methods). While for both decomposition directions the first 618 mode was clearly discernible in its deviance from the theoretical distribution, a number of subsequent 619 modes also reflected signal (21 modes in Figure 5a , 26 modes in Figure 5c ). Yet, two observations 620 indicated that the first spatial modes (for both decomposition directions) captured the predominant 621 effects of atomoxetine. First, they tended to explained a larger proportion of variance in one condition 622 relative to another than the remaining ones: for both decomposition directions, the ROC index was 623 strongly negatively correlated with mode rank number (Figure 5b,d) . Second, the first spatial mode 624 exhibited significantly stronger correlations with the distributions of catecholamine receptors than the 625 subsequent signal modes (Figure 5e,f) , and no individual signal mode correlated more strongly with 626 catecholamine receptors than the first mode (smallest corrected p-values and Bayes Factors: 627 atomoxetine > placebo: p = 0.13, BF = 0.93; placebo > atomoxetine: p = 0.28, BF = 0.75). Thus, the 628 first mode optimally reflected atomoxetine-induced changes in signal correlation strength in relation 629 to the distribution of specific catecholamine receptors.
fluctuations 632
The linear decomposition analysis performed here, by design, returned a spatial mode of 633 which the fluctuation strength differed between the two conditions that were used to calculate the 634 spatial mode (here: atomoxetine and placebo). Our reliability analyses established that the two spatial 635 modes shown in Figures 2b and 3b accurately discriminated between pharmacological conditions, 636 even in short stretches of data independent from the ones used to identify the modes (Figures 2d,e and  637 3d,e). This establishes that both spatial modes captured meaningful alterations of brain dynamics, 638 rather than measurement noise. Nevertheless, they may have reflected changes in brain dynamics that 639 differed systematically between the placebo and atomoxetine sessions, without reflecting specific 640 drug treatment effects. Specifically, because both sessions took place one week apart, it was possible 641 that the spatial modes might have reflected the session rather than the treatment. 642
We addressed this concern by analyzing the pre-pill ingestion fMRI measurements that took 643 place on the same days. We projected the spatial modes onto the multivariate fMRI data of the pre-pill 644 explained, see eqn. 6 in the Materials and Methods). If the spatial modes reflected changes in brain 655 dynamics that were specifically due to the catecholaminergic intervention rather than to session 656 differences, then (i) their fluctuation amplitudes should differ more for the post-pill measurements 657 than for the pre-pill measurements, and (ii) spatial modes computed in an analogous fashion for the 658 pre-pill ingestion conditions should exhibit a different spatial structure from the spatial modes we 659 investigated so far. That is what we found ( Figure 6) . First, the interaction contrast (atomoxetine -pre 660 atomoxetine) -(placebo -pre placebo) was significant, in the expected direction for both spatial 661 modes analyzed here (Figure 6a) . Second, the spatial modes that were computed for the pre-pill 662 measurements (Figure 6b ) did not resemble those from the post-pill measurements (compare with 663 Figures 2b and 3b) , with no significant spatial correlations (all absolute r values < 0.06, all p values > 664 0.60). Taken together, these control analyses rule out session-related effects as a confound and further 665 establish that the spatial modes assessed in the previous sections reflected drug-induced changes in 666 brain dynamics. 667 668
Control 3: Craddock parcellation yields similar results as AAL parcellation 669
In order to rule out that our results depended on the specific anatomical parcellation scheme 670 used for computing the spatial modes (AAL), we repeated the analyses using an alternate atlas that 671 resulted from a functional parcellation and had a higher density (Craddock et al., 2012) . Both 672 resulting spatial modes explained more variance in one condition than in the other, in the expected 673 direction (atomoxetine > placebo: p < 0.001; placebo > atomoxetine: p < 0.001). Again, these effects 674
were reliable at the level of independent and short (~114 s) data segments (atomoxetine > placebo: p 675 < 0.001; placebo > atomoxetine: p < 0.001). Thus, the Craddock parcellation also yielded spatial 676 modes that reliably differed between the two pharmacological conditions in terms of fluctuation 677 strength. 678
The resulting spatial modes were also similar to the ones from our main analyses in terms of 679 their spatial structure. To establish this, we again imaged the expression of the spatial mode time 680 series across all brain voxels and compared the resulting map to the corresponding map from the AAL 
687
differed both in the number of brain regions and in the way the brain regions were defined 688 (anatomical parcellation and functional clustering, respectively), the mode spatial maps generated 689 with the two atlases corresponded robustly across participants for the spatial mode atomoxetine > 690 placebo (placebo: t(23) = 3.96, p < 0.001; atomoxetine: t(23) = 3.98, p < 0.001, Figure 7) . Moreover, 691 the spatial modes, imaged at single-voxel level, correlated between drug conditions (AAL atlas: t(23) 692 = 6.93, p < 0.001; Craddock atlas: t(23) = 14.89, p < 0.001; Figure 7 ). This was also the case for the 693 spatial mode placebo > atomoxetine: spatial modes correlated across atlases (placebo: t(23) = 10.43, p 694 < 0.001; atomoxetine: t(23) = 9.54, p < 0.001; Figure 8 ) and drug conditions (AAL: t(23) = 15.57, p < 695 0.001; Craddock: t(23) = 14.89, p < 0.001; Figure 8 ). In sum, the Craddock atlas-derived modes 696 yielded similar results in terms of direction and significance of effects as well as spatial structure of 697 the resulting spatial modes. 
701
The r values indicate the average correlation coefficients across participants.
703
Control 4: Artifacts in global signal do not account for main results
704
Recent findings have suggested that the global MRI signal may contain artifacts that are 705 related to various non-neural sources, and these artifacts are not effectively removed by standard 706 preprocessing techniques (Power et al., 2017) . Such artifacts may have caused spurious differences 707 between conditions in the structure of inter-regional covariance. We therefore applied global signal 708
(the mean of all regional time series) regression to the regional BOLD time series prior to computing 709 covariance matrices, and repeated our key spatial mode decomposition analyses. 710
For the decomposition atomoxetine > placebo, the percentage variance explained of mode 1 711 differed between conditions and in the expected direction (AAL: t(23) = 4.45, p < 0.001, ROC index 712 = 0.64, t(23) = 6.88, p < 0.001; Craddock: t(23) = 4.55, p < 0.001, ROC index = 0.69, t(23) = 7.54, p 713 < 0.001). For the decomposition placebo > atomoxetine the percentage variance explained of mode 1 714 also differed between conditions and in the expected direction (AAL: t(23) = -5.15, p < 0.001, ROC 715 index = 0.63, t(23) = 8.97, p < 0.001; Craddock: t(23) = -6.23, p < 0.001, ROC index = 0.63 t(23) = 716 7.06, p < 0.001). Moreover, the spatial structure of the modes that included global signal regression 717 was similar to that of the modes that did not include global signal regression, as indicated by 718 significant correlations between mode weights (all r values > 0.42, all p values < 0.001). Thus, our 719 findings were unlikely to be driven by spurious differences between conditions relating to artifacts in 720 the global signal. 721 722 Control 5: Differences in peripheral physiology do not account for main results
723
Because atomoxetine significantly increased both heart rate and breath rate (atomoxetine vs 724 placebo: heart rate: t(23) = 3.24, p = 0.004; breath rate: t(23) = 3.02, p = 0.006), it is possible that the 725 RETROICOR denoising procedure operated differently in the atomoxetine and placebo conditions, 726 thereby conceivably introducing spurious changes in the structure of inter-regional covariance. We 727 therefore repeated the spatial mode decomposition analyses on data to which no RETROICOR had 728 been applied. For both atlases and for both decomposition directions, all between-condition 729 comparisons of variance explained by the modes were significant and in the expected direction (AAL, 730 atomoxetine > placebo: p < 0.001; ROC index: 0.62, p < 0.001; Craddock, atomoxetine > placebo: p < 731 0.001; ROC index: 0.63, p < 0.001; AAL, placebo > atomoxetine: p < 0.001; ROC index: 0.62, p < 732 0.001; Craddock, placebo > atomoxetine: p < 0.001; ROC index: 0.63, p < 0.001). Moreover, to 733 examine if the modes that resulted from decomposition of non-RETROICOR-corrected data were 734 similar in spatial structure to the modes that resulted from decomposition of RETROICOR-corrected 735 data, we correlated the mode weights between the RETROICOR-corrected and non-corrected modes. 736
All correlations were significant, (all r values > 0.47, all p values < 0.001), thus ruling out the 737 possibility that the modes reflected between-condition differences in peripheral physiology. 738 739 Control 6: Eigenvalue decomposition identifies similar networks as ICA . We verified that the linear decomposition approach used here identified similar 743 spatial patterns. To this end, we selected voxel-level mode maps based on maximal spatial correlation 744 with the 10 intrinsic connectivity networks reported by . For the placebo condition, 745 the average correlation coefficient was 0.41 (SD 0.12, min 0.16, max 0.56) , and for the atomoxetine 746 condition the average correlation coefficient was 0.40 (SD 0.12, min 0.15, max 0.53) . Similar results 747
were obtained with the Craddock atlas. 
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Spatial maps were visualized with BrainNet Viewer (Xia et al., 2013). and Cohen, 2005; Robbins and Arnsten, 2009; McGinley et al., 2015) . A substantial body of work has 758 characterized the catecholaminergic modulation of single neuron activity (Berridge and Waterhouse, 759 2003; Winterer and Weinberger, 2004) or micro-circuit operations (Marder, 2012; Polack et al., 760 2013) . Fewer studies have assessed catecholaminergic modulation of large-scale brain network 761 dynamics. Pharmacological fMRI studies in monkeys and humans have shown that catecholamines 762 alter the strength of correlations between distant brain regions (Hermans et al., 2011; Guedj et al., 763 2016; van den Brink et al., 2016; Warren et al., 2016; Hernaus et al., 2017) . While 'resting-state' 764 studies have reported catecholamine-induced decreases in correlation strength (van den Brink et al., 765 2016; Guedj et al., 2017) , task-based studies have reported increases Hernaus et 766 al., 2017) , or the converse for noradrenergic antagonism (Hermans et al., 2011) . Critically, the brain-767 wide distribution of these modulatory effects has thus far remained unknown. 768
Here, we imaged the brain-wide distribution of catecholamine-induced changes in intrinsic 769 correlations across the human brain and related the resulting spatial patterns of brain dynamics to the 770 brain-wide distribution of specific catecholamine receptors. We thus applied an analysis approach 771 tailored to delineate spatial patterns of both drug-induced increases and decreases in correlation 772 strength ( Figure 1) to 'resting-state' fMRI data from a placebo-controlled atomoxetine intervention. 773
This uncovered two distinct, and widely distributed, sets of brain regions (Figures 2,3) , each of which 774 showed a distinct spatial correspondence to the brain-wide distribution of catecholamine receptor 775 genes, but not acetylcholine or NMDA receptor genes (Figure 4) . Our results establish that the impact 776 of catecholamines on brain network dynamics exhibits remarkable spatial specificity. Our results 777 bridge between the endogenous modulation of large-scale brain network dynamics and the low-level 778
properties of the underlying neurotransmitter systems. 779
The catecholaminergic system is equipped with a large variety of receptor types, which are 780 non-uniformly distributed across the cortex (Zilles and Amunts, 2009; Nahimi et al., 2015; Salgado et receptors have relatively low affinity for NE and are therefore activated only at relatively high 784 synaptic NE levels (e.g., due to stress). These receptors seem to weaken cortical circuit interactions 785 (Ramos and Arnsten, 2007) , an interesting observation given that the spatial distribution of these 786 receptors was specifically associated with the spatial mode that captured a catecholamine-induced 787 suppression of fMRI signal correlations. By contrast, the spatial mode atomoxetine > placebo (i.e., 788 enhancement of correlations) was associated with the expression of D2-like receptors, which have 789 been associated with cortical disinhibition (Seamans et al., 2001; Winterer and Weinberger, 2004) , 790
and some of which also show particularly high affinity for NE (Arnsten, 2011) . Thus, it is possible 791 that inhibition / disinhibition of local populations of neurons cause, by virtue of widespread receptor 792 expression, large-scale decreases / increases in correlation strength respectively. Regardless of the 793 precise mechanistic origin of changes in correlation strength, our findings suggest that the diversity in 794 distribution and function of catecholamine receptors is responsible, at least in part, for the opposite 795 sign modulations of correlations we uncovered here. 796
This insight is in accordance with the emerging view of the LC-NE system as a more specific 797 regulator of brain-wide neural interactions than traditionally assumed. In addition to the receptor 798 heterogeneity across the brain that we focused on here, recent results indicate that the ascending 799 projections of the LC are more spatially specific than once thought (Chandler and Waterhouse, 2012; 800 Chandler et al., 2014; Uematsu et al., 2015; Kebschull 801 et al., 2016; Uematsu et al., 2017) . Furthermore, distinct subpopulations of LC neurons mediate 802 opposite behavioral effects (Uematsu et al., 2017) , and could thus also affect the underlying neural 803 interactions in dichotomous ways. 804
In our previous work, we identified atomoxetine-related reductions in signal correlation 805 strength at the whole-brain level . Other fMRI work has revealed similar 806 global changes in the strength of correlations, due to pupil-linked arousal (Eldar et al., 2013; Warren 807 et al., 2016) , pharmacological intervention (Hermans et al., 2011; Warren et al., 2016) , and concurrent 808 alterations in the topological properties of whole-brain cofluctuations (Shine et al., 2016; opposing atomoxetine-related effects in different sets of brain regions that we identified here. 811
However, our analysis approach was specifically tailored to delineate the predominant catecholamine-812 induced changes in fluctuations. Thus, our findings do not rule out the possibility of spatially 813 homogenous modulations of correlations due to catecholamines -they only show that such potential 814 global effects accounted for a smaller proportion of variance than the spatially-specific 815 catecholamine-related changes focused on here. Our current findings should thus be viewed as 816 complementary to previous work, offering a detailed view of the predominant aspects of 817 catecholamine-modulated correlations. 818
The brain-wide effects of catecholaminergic manipulation observed here stand in striking 819 contrast to the recently reported effects of a cholinergic manipulation (deactivation of the nucleus 820 basalis). The latter attenuates the so-called "global MRI signal" (i.e., averaged across all gray matter 821 voxels) at rest while leaving the structure of specific resting-state networks relatively unaltered 822 (Turchi et al., 2018) . Instead, we found that the catecholamine-induced effects are heterogeneous, 823 affecting specific functional networks. Thus, the catecholaminergic and cholinergic systems -despite 824 similarly widespread ascending projections -may have dissociable influences on large-scale brain 825
activity. 826
Noteworthy is that both spatial modes exhibited a negative correlation between homotopic 827 brain regions. Similar left-right asymmetries in endogenous NE concentration (Oke et al., 1978) and 828 noradrenergic modulations of correlations (Grefkes et al., 2010) have previously been reported. The 829 'bilaterally-opponent' structure we observed (Figures 2b,3b ) may have resulted from modulation of 830 inter-hemispheric anatomical connectivity, via direct or indirect pathways, as homotopic brain regions 831 are strongly interconnected (Segraves and Rosenquist, 1982; Lim et al., 2012) . In this scenario, 832 catecholamines simply modulated the functional efficacy of the structural connectome. Another (non-833 mutually exclusive) possibility is that this bilaterally-opponent structure resulted from the spatial 834 structure of the unilateral ascending projections from the left and right LC to the cortex. In addition, 835 atomoxetine shifted correlations from left-lateralized to right-lateralized frontoparietal networks, an 836 observation corroborated by correlation with ICA-derived 'resting state networks'. Indeed, right-goal-oriented stimulus processing (Corbetta and Shulman, 2002; Corbetta et al., 2008) . It is tempting 839 to speculate (participants were not engaged in a task) that our current results indicate an atomoxetine-840 related shift towards goal-oriented stimulus processing, a hypothesis that could be tested in future 841
work. 842
The current study showcases the utility of generalized eigenvalue decomposition for the 843 analysis of resting-state fMRI data. One of its primary advantages over conventional analysis 844 techniques (e.g. dual regression, (Beckmann, 2009) ) is that it does not require an a priori selection of 845 functional networks, but instead yields the spatial modes that show the strongest drug effects. Thus, it 846 increases the sensitivity to potentially more subtle drug-related changes, as evidenced by the 847 atomoxetine-induced increases in correlated fluctuations that were not identified in our previous study 848 . The approach also has limitations. First, although we demonstrated 849 robustness of results across two particular parcellation schemes, the resulting spatial modes might 850 differ for other parcellation schemes, in particular those of radically different densities. Second, the 851 approach can only be used to compare correlations between two conditions (or groups), limiting its 852 applicability for more complex (e.g., longitudinal) study designs. Third, the approach required 853 focusing on one or a few out of the large number of spatial modes yielded by the decomposition. 854
An examination of all potential modes of interest revealed that several modes other than the 855 first exhibited statistically significant differences between condition (Figure 5b,d) . Each of these 856 modes may have captured meaningful information about atomoxetine-related changes in correlations. 857
We focused on the first mode for a number of reasons. First, orthogonality between the spatial modes 858 that is imposed by the analysis could obscure the interpretation of modes subsequent to the first. 859
Second, for both decomposition directions, the first spatial mode tended to account for more variance 860 in independent data than subsequent modes (Figure 5a-d) . We thus used it as a readout of the 861 predominant effect of atomoxetine on correlation strength. Third, for both decomposition directions, 862 the first spatial mode captured the strongest association with the distribution of specific catecholamine 863 receptors (Figure 5e,f) . 864
In sum, we have shown that catecholamines increase and decrease the strength of intrinsic 865 fMRI signal correlations within two distinct sets of distributed brain regions. These spatially-specific 866 and opposite-polarity modulations of ongoing brain dynamics mirror the spatial receptor diversity 867 within the catecholaminergic system. Our results provide a reference for understanding 868 catecholaminergic effects on network interactions during task performance, and important constraints 869 for modeling catecholaminergic effects on the forebrain. 870
